Viral Vaccines
- Name
- Viral Vaccines
- Accession Number
- DBCAT002012
- Description
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
- ATC Classification
- Drugs
Drug Drug Description Varicella zoster vaccine (live/attenuated) Zostavax vaccine is indicated for the prevention of herpes zoster (shingles) in immunocompetent adults aged 50 years and older. Varivax vaccine is indicated for active immunization for the prevention of... Yellow fever vaccine Yellow Fever Vaccine is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older in the following categories: Persons Living in or... Rotavirus vaccine Rotarix is indicated for prevention of rotavirus gastroenteritis caused by G1, G3, G4, and G9 types in infants aged 6-24 weeks [FDA Label]. Rotateq is indicated for the prevention of... Rubella virus vaccine A vaccine used to prevent Rubella. Ebola Zaire vaccine (live, attenuated) A vaccine used in the prophylaxis of Ebola virus disease caused by the species of Zaire ebolaviruses. Smallpox (Vaccinia) Vaccine, Live The live antigen of the New York City Board of Health strain of Vaccinia is indicated (within the ACAM2000 formulation) for active immunization against smallpox disease in patients determined to... Human adenovirus e serotype 4 strain cl-68578 antigen Human adenovirus e serotype 4 strain cl-68578 antigen is a vaccine. Adenovirus type 7 vaccine live Not Annotated Tick-borne encephalitis vaccine (whole virus, inactivated) A whole inactivated viral vaccine against meningoencephalitis caused by the tick-borne encephalitis virus. Tozinameran An mRNA vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus. Moderna COVID-19 Vaccine An mRNA vaccine for the prevention of COVID-19, the disease caused by the SARS-CoV-2 virus, in patients aged 18 years and older. Janssen COVID-19 Vaccine An adenovirus-based vaccine used for active immunization against COVID-19 caused by SARS-CoV-2 infection. Nuvaxovid A recombinant spike (S) protein vaccine for the prevention of COVID-19 caused by SARS-CoV-2. Rabies virus inactivated antigen, A Rabies virus inactivated antigen, A is an inactivated virus vacine for the intramuscular injection. It is an active immunization against rabies that can be administered pre- or post-exposure to the... Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) Not Annotated Dengue tetravalent vaccine, live Not Annotated Hepatitis A Vaccine An inactivated vaccine against infection with the Hepatitis A virus. Hepatitis B Vaccine (Recombinant) A solution of Hepatitis B surface antigen used to immunize patients against Hepatitis B. AstraZeneca COVID-19 Vaccine A two-dose replication-deficient adenovirus vector vaccine used to prevent COVID-19 caused by SARS-CoV-2. INO-4800 INO-4800 is a DNA vaccine containing the full sequence for the SARS-CoV-2 Spike (S) protein in development for immunization against COVID-19. Early in vitro studies using HEK-293T cells demonstrated that... BNT162b1 SARS-CoV-2 Vaccine BNT162b1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding... BBIBP-CorV BBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. Investigation shows this vaccine induces neutralizing antibodies in several mammalian species while also showing protective efficacy with SARS-CoV-2 challenge in... Bizalimogene ralaplasmid Bizalimogene ralaplasmid is under investigation in clinical trial NCT03499795 (VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 And/or HPV-18 Related Anal or Anal/peri-anal, High Grade... Pidacmeran Pidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults). BNT-162A1 BNT-162A1 is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults). SARS-CoV-2 vaccine SARS-CoV-2 vaccine is an adjuvanted recombinant protein-based COVID-19 vaccine candidate being developed collaboratively by GlaxoSmithKline (GSK) and Sanofi[L30405, L30410, L30415]. This vaccine candidate is composed of a spike protein antigen... EpiVacCorona EpiVacCorona Vaccine, developed by the Vektor State Research Center of Virology and Biotechnology in Russia, is based on peptide-antigens that facilitate immunity to the SARS-CoV-2 virus . It is currently... Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccine A vaccine comprising purified SARS-CoV-2 spike protein expressed in plant-based virus-like particles for the prevention of COVID-19 in adult patients. Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) An influenza antigen used in seasonal influenza vaccines. Influenza A virus A/Hong Kong/2671/2019 IVR-208 (H3N2) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus Yamagata lineage haemagglutinin, recombinant Not Annotated Influenza B virus Victoria lineage haemagglutinin, recombinant Not Annotated Influenza A virus subtype H1N1 haemagglutinin, recombinant Not Annotated Influenza A virus subtype H3N2 haemagglutinin, recombinant Not Annotated Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated) Not Annotated Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Wisconsin/588/2019 (H1N1) recombinant hemagglutinin antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Washington/02/2019 recombinant hemagglutinin antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Tasmania/503/2020 (H3N2) live (attenuated) antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/1/2020 (H1N1) live (attenuated) antigen Not Annotated Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (UV, formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (UV, formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Tasmania/503/2020 (H3N2) antigen (MDCK cell derived, propiolactone inactivated) In combination with other influenza virus subtypes A and types B strains, this Influenza A viral strain is used for active immunization of adults and children aged 6 months or... Influenza A virus A/Washington/19/2020 (H1N1) antigen (MDCK cell derived, propiolactone inactivated) In combination with other influenza virus subtypes A and types B strains, this Influenza A viral strain is used for active immunization of adults and children aged 6 months or... Influenza A virus A/Tasmania/503/2020 (H3N2) recombinant hemagglutinin antigen Not Annotated Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen A component of a live attenuated influenza vaccine. Influenza B virus B/Austria/1359417/2021 live (attenuated) antigen A component of a live attenuated influenza vaccine. Influenza A virus A/Darwin/6/2021 IVR-227 (H3N2) antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Austria/1359417/2021 BVR-26 hemagglutinin antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Singapore/WUH4618/2021 antigen (MDCK cell derived, propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Darwin/11/2021 (H3N2) antigen (MDCK cell derived, propiolactone inactivated) A component of an inactivated influenza vaccine Influenza A virus A/Delaware/55/2019 CVR-45 (H1N1) antigen (MDCK cell derived, propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Darwin/9/2021 SAN-010 (H3N2) antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Michigan/01/2021 antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Darwin/6/2021 IVR-227 (H3N2) antigen (propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Darwin/6/2021 (H3N2) recombinant hemagglutinin antigen A component of a recombinant influenza vaccine comprising a recombinant influenza hemagglutinin antigen. Influenza B virus B/Austria/1359417/2021 recombinant hemagglutinin antigen A component of a recombinant influenza vaccine comprising a recombinant influenza hemagglutinin antigen. Influenza A virus A/Darwin/9/2021 IVR-228 (H3N2) antigen (UV, formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (UV, formaldehyde inactivated) A component of an inactivated influenza vaccine. Davesomeran An mRNA vaccine in combination with the Moderna COVID-19 vaccine to prevent infection from the Omicron variant of the SARS-CoV-2 virus in people 6 years old or older. Famtozinameran A component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineages BA.4 and BA.5. Imelasomeran A component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineage BA.1. Riltozinameran A component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineage BA.1. Modified vaccinia ankara A live, non-replicating orthopoxvirus vaccine used to prevent smallpox, monkeypox, and other diseases caused by vaccinia virus. SCB-2019 SCB-2019 is a recombinant trimeric S protein subunit vaccine candidate being investigated against COVID-19. This vaccine candidate resembles the native trimeric viral spike and is produced through mammalian cell-culture. The... CoronaVac CoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation . It was developed by propagating the SARS-CoV-2 CN2 strain inside... CVnCoV Vaccine The CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate... BBV152 BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR). The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV-2 strain and... CoVac-1 Sponsored by the University Hospital Tuebingen in Germany, CoVac-1 is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein . It is... UB-612 The UB-612 COVID-19 vaccine was developed by United Biomedical Inc Asia in Taipei as the first COVID-19 “multi-tope” protein-peptide vaccine made up of eight rationally designed components . The vaccine... Tubimod Not Available GSK-3844766A An adjuvanted respiratory syncytial virus vaccine in older adults. Influenza A Virus A/Sydney/5/2021 SAN-013 (H1N1) antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Remune Not Available Influenza A Virus A/Victoria/4897/2022 IVR-238 (H1N1) antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/West Virginia/30/2022 (H1N1) Recombinant Hemagglutinin Antigen A component of a recombinant influenza vaccine comprising a recombinant influenza hemagglutinin antigen. Influenza A virus A/Georgia/12/2022 CVR-167 (H1N1) Antigen (MDCK cell derived, propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Victoria/4897/2022 IVR-238 (H1N1) Antigen (propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Victoria/4897/2022 IVR-238 (H1N1) Antigen (UV, formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Norway/31694/2022 (H1N1) live (attenuated) antigen A component of a live attenuated influenza vaccine. - Drugs & Drug Targets
Drug Target Type Hepatitis A Vaccine B-lymphocytes target